Page 3 - கிரிஸ்டல் பயோடெக் இன்க் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Krystal Biotech Announces Pricing of Upsized $125 Million Public Offering of Common Stock February 02, 2021 20:51 ET | Source: Krystal Biotech, Inc. Krystal Biotech, Inc. Pittsburgh, Pennsylvania, UNITED STATES PITTSBURGH, Feb. 02, 2021 (GLOBE NEWSWIRE) Krystal Biotech Inc. (NASDAQ: KRYS) (the “Company), the leader in redosable gene therapies for rare diseases, today announced that it has priced the previously announced underwritten public offering of 1,923,077 shares of its common stock, at a public offering price of $65.00 per share. The Company granted the underwriters a 30-day option to purchase up to an additional 288,461 shares of its common stock. The gross proceeds to the Company from this offering are expected to be approximately $125 million, before deducting the underwriting discounts and commissions and other estimated offering expenses payable by the Company. The offering is expected to close on or about Februar

New yorkUnited statesWhitney ijemKrystal biotech incBroadridge financial solutionsHc wainwright coCompany annual report on formExchange commissionLadenburg thalmann coProspectus departmentGoldman sachs coEvercore groupLadenburg thalmannGoldman sachsIsland avenueEquity capital markets